|
Cerca
in questa pagina
|
|
LE
PIU' RECENTI LINEE GUIDA MONDIALI,
EUROPEE E NAZIONALI PER IL CONTROLLO DEI LIPIDI PLASMATICI NELLA PREVENZIONE CARDIOVASCOLARE |
|
ESC/EAS
Guidelines |
|
AHA
Scientific Statement |
|
AHA/ASA
Presidential Advisory |
|
AMD-SID |
|
NICE
- National Institute for Health and Clinical Excellence |
|
Stroke
PRevention and Educational Awareness Diffusion |
|
Gruppo
di Consensus SITeCS |
|
AHA
Special Report |
|
AHA
Statistical Update |
|
ACCF/AHA
practice guidelines |
|
ACCF/AHA
practice guidelines |
|
ESH
Guidelines |
|
Gruppo
di Consensus sulla LDL-aferesi |
|
Joint
Scientific Statement |
| U.S.
Preventive Services Task Force Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment U.S. Preventive Services Task Force Recommendation Statement |
| U.S.
Preventive Services Task Force C-Reactive Protein as a Risk Factor for Coronary Heart Disease A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force |
| U.S.
Preventive Services Task Force Emerging Risk Factors for Coronary Heart Disease A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Policy Statement |
|
ESH
Guidelines |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
Competence
and Training Statement |
|
ACCF/AHA
Performance Measures |
|
ESC
Guidelines |
|
AHA
Scientific Statement |
|
AHA
Science Advisory |
|
AHA
Science Advisory |
|
AHA
Scientific Statement |
|
NICE
- National Institute for Health and Clinical Excellence |
|
NICE
- National Institute for Health and Clinical Excellence |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Scientific Statement |
|
AHA/ASA
Scientific Statement |
|
AHA/ASA
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA
Conference Proceedings |
|
ACCF/AHA
Practice Guideline |
|
AHA
Scientific Statement |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA/ACCF/HRS
Scientific Statement |
|
AHA
Science Advisory |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Science Advisory |
|
NICE
- National Institute for Health and Clinical Excellence |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Scientific Statement |
|
ACCF/SCAI/STS/AATS/AHA/ASNC
2009 Report |
|
ADA/ACC/AHA
Position Statement |
|
AHA
Conference Proceedings |
|
AHA
Data Standards |
|
AHA
Statistical Update |
|
Gruppo
di Consensus SITeCS |
|
Endocrine
Society Clinical Practice Guideline |
|
ESC
Guidelines |
|
ACC/AHA
Performance Measures |
|
ACC/AHA
Guideline |
|
ILCOR
Scientific Statements |
|
ESC
Guidelines |
|
ACCF/ACG/AHA
Expert Consensus Document |
|
AHA
Policy Statement |
|
ESC
Guidelines |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Science Advisory |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA/ACCF/HRS
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA/ACCF
Scientific Statement |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Special Report |
|
AHA
Special Report |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
ACC/AHA/HRS
2008 Guidelines |
|
ESC
Guidelines |
|
ACC
Consensus Conference Report |
|
The
Cochrane Library |
|
NICE
- National Institute for Health and Clinical Excellence |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA/ASA
Recommendations |
|
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR
Appropriateness Criteria |
|
AHA
Scientific Statement |
|
AHA
Statistical Update |
|
ACC/AHA
Guidelines |
|
ACC/AHA
Guideline Revision |
|
ESC
Guidelines |
|
ESC/ACCF/AHA/WHF
Guidelines |
|
ACCF/AHA
Clinical Competence Statement |
|
ESC
Guidelines |
|
ESC
Guidelines |
|
AHA
Scientific Statements |
|
ESH/ESC
Guidelines |
|
ACCF/AHA/SCAI
2007 Scientific
Update |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA/AACVPR
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA/ASA
Guideline |
|
AHA
Scientific Statement |
|
AHA
Guideline |
|
AHA/ASA
Guideline |
|
AHA
Conference Proceedings |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
ESC/EASD
Guidelines |
|
AHA
Statistical Update |
|
ESC
Guidelines |
|
ACC/AHA/ESC
Practice Guidelines |
|
AHA
Scientific Statement |
|
AHA
Guidelines |
|
AHA/ADA
Scientific
Statement |
|
AHA
Science Advisory |
|
AHA
Special
Report |
|
Nota
13 - AIFA 2006-2007 |
|
ACC/AHA/ESC
Guidelines |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
AHA
Scientific Statements |
|
AHA
Scientific Statement |
|
ACC/AHA
Guidelines |
|
AHA
Scientific Statement |
|
AHA/ASA
Guideline |
|
ACC/AHA
Practice Guidelines |
|
AHA/ACC
Guideline |
|
AHA
Scientific Statement |
|
AHA/ASA
Guidelines |
|
AHA
Scientific Statement |
|
AHA
Scientific Statement |
|
ACC/AHA/SCAI
Practice Guideline |
|
ACC/AHA
Guidelines |
| Taking
the Initiative Implementing the American Heart Association Guide for Improving Cardiovascular Health at the Community Level: Healthy People 2010 Heart Disease and Stroke Partnership Community Guideline Implementation and Best Practices Workgroup |
| Dietary
Recommendations for Children and Adolescents A Guide for Practitioners: Consensus Statement From the American Heart Association |
| Medical
Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary
Prevention Programs A Scientific Statement From the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation |
| Managing
Abnormal Blood Lipids: A Collaborative Approach |
| Major
Ongoing Stroke Trials |
| A
new definition for myocardial infarction: what difference does it make? |
| Diagnosis
and Management of the Metabolic Syndrome An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement |
|
ACC/AHA
PRACTICE GUIDELINES |
|
ACC/AHA
HEART FAILURE CLINICAL PERFORMANCE MEASURES |
|
ACC/AHA
HEART FAILURE CLINICAL DATA STANDARDS |
| Exercise
Testing in Asymptomatic Adults: A Statement for Professionals From the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention |
| Management
of Adult Stroke Rehabilitation Care: A Clinical Practice Guideline |
| Veterans
Affairs/Department of Defense Clinical Practice Guideline for the Management
of Adult Stroke Rehabilitation Care: Executive Summary AHA/ASA-Endorsed Practice Guidelines |
| A
Report of the ACCF/AHA/American College of Physicians Task Force on Clinical
Competence and Training: Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging, and the Society for Cardiovascular Angiography & Interventions: Endorsed by the Society of Cardiovascular Computed Tomography |
| Major
Clinical Trials of Hypertension: What Should Be Done Next? The National Heart, Lung, and Blood Institute Working Group on Future Directions in Hypertension Treatment Trials |
| Recommendations
for Comprehensive Stroke Centers A Consensus Statement From the Brain Attack Coalition |
| Guidelines
for the Diagnosis and Treatment of Chronic Heart Failure The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology |
| Recommendations
for the Establishment of Stroke Systems of Care Recommendations From the American Stroke Associations Task Force on the Development of Stroke Systems |
| Recommendations
for Blood Pressure Measurement in Humans and Experimental Animals - Part
I Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Recommendations for Blood Pressure Measurement in Humans and Experimental Animals - Part II Part 2: Blood Pressure Measurement In Experimental Animals: A Statement for Professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research |
| Cardiac
Rehabilitation and Secondary Prevention of Coronary Heart Disease An American Heart Association Scientific Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation |
| Clinical
Implications of Obesity With Specific Focus on Cardiovascular Disease A Statement for Professionals From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation |
| Cardiovascular
Health Promotion in the Schools A Statement for Health and Education Professionals and Child Health Advocates From the Committee on Atherosclerosis, Hypertension, and Obesity in Youth (AHOY) of the Council on Cardiovascular Disease in the Young, AHA |
| Evaluation
of Primary Care Patients with Chronic Stable Angina: Guidelines from the
American College of Physicians Update of the 1999 guidelines on chronic stable angina published by the ACP and ACC/AHA |
| Implications
of Recent Clinical Trials for the National Cholesterol Education Program
Adult Treatment Panel III Guidelines Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) |
| Principles
for National and Regional Guidelines on Cardiovascular Disease Prevention A Scientific Statement From the World Heart and Stroke Forum Commento tratto da SEFAP Servizio di Epidemiologia e Farmacologia Preventiva |
| Evidence-Based
Guidelines for Cardiovascular Disease Prevention in Women American Heart Association Commento tratto da SEFAP Servizio di Epidemiologia e Farmacologia Preventiva |
| Harmonized
Guidelines on Prevention of Atherosclerotic Cardiovascular Disease International Atherosclerosis Society |
| European
Guidelines on Cardiovascular Disease Prevention in Clinical Practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice Commento a cura di Domenico Sommariva e Adriana Branchi |
| International
Task Force for Prevention of Coronary Heart Disease |
| Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Panel III) |
| Linee
Guida SISA relative all’identificazione ed al trattamento delle dislipidemie
nella prevenzione delle malattie cardiovascolari Congresso Nazionale - Chieti, 27-30 Novembre 2002 |
| Decreto
legislativo sulla protezione dei dati personali G.U. n. 174 del 29.07.2003 - Suppl. Ord. n.123 Testo in vigore dal 1.1.2004 |